Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL160 (27-400, ANTIBIOTIC S-7481F1, Atopica, Capimune, Capsorin, Cequa, Ciclosporin, Ciclosporin a, Ciclosporinum, Cyclosporin, Cyclosporin a, Cyclosporine, Cyclosporine a, Cyclosporine microemulsion, Cyclosporine, modified, Deximune, Equoral, Gengraf, Ikervis, Mitogard, Neoplanta, Neoral, Neurostat, NSC-290193, OL-27-400, Optimmune, Ramihyphin a, Restasis, Restasis multidose, Sandimmun, Sandimmune, SANG-35, Sangcya, SDZ-OXL-400, Vanquoral, Verkazia, Zinograf me) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ABCG2/ATP-binding cassette sub-family G member 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5393] [GtoPdb: 792] [UniProtKB: Q9UNQ0] | ||||||||
GtoPdb | Inhibition of ABCG2-ATPase activity induced by substrate binding. | - | 6.3 | pKi | 500 | nM | Ki | Biochem Biophys Res Commun (2001) 285: 111-7 [PMID:11437380] |
ChEMBL | TP_TRANSPORTER: inhibition of ATPase in membrane vesicle from BCRP-expressing Sf9 cells | F | 6.3 | pKi | 500 | nM | Ki | Biochem. Biophys. Res. Commun. (2001) 285: 111-117 [PMID:11437380] |
ChEMBL | Inhibition of ABCG2 in human mitoxantrone-resistant MCF7 cells by Hoechst 33342 assay | B | 4.2 | pIC50 | 63095.73 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 8224-8236 [PMID:18678495] |
ChEMBL | Inhibition of sulfasalazine-stimulated BCRP ATP ase activity (unknown origin) | B | 5.18 | pIC50 | >6568 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
ChEMBL | Inhibition of BCRP (unknown origin) transfected in HEK293/R2 cells assessed as reversal of topotecan resistance after 5 days by MTS/PMS assay | B | 5.76 | pEC50 | 1750 | nM | EC50 | J Med Chem (2019) 62: 8578-8608 [PMID:31465686] |
Sodium/bile acid and sulphated solute cotransporter 1/Bile acid transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5287] [GtoPdb: 959] [UniProtKB: Q14973] | ||||||||
GtoPdb | - | - | 5.12 | pKi | 7600 | nM | Ki | Mol Pharm (2013) 10: 1008-19 [PMID:23339484] |
GtoPdb | - | - | 6 | pIC50 | 1000 | nM | IC50 | J Pharmacol Exp Ther (1999) 291: 1204-9 [PMID:10565843] |
ChEMBL | TP_TRANSPORTER: inhibition of Taurocholate uptake in NTCP-expressing HeLa cells | F | 6 | pIC50 | 1000 | nM | IC50 | J. Pharmacol. Exp. Ther. (1999) 291: 1204-1209 [PMID:10565843] |
ABCB11/Bile salt export pump in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6020] [GtoPdb: 778] [UniProtKB: O95342] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Taurochenodeoxycholate uptake(CsA 30uM, 30 % of control) in membrane vesicles prepared from High Five cells infected with the ABCB11 baculovirus | F | 5.02 | pKi | 9500 | nM | Ki | Gastroenterology (2002) 123: 1649-1658 [PMID:12404239] |
ChEMBL | TP_TRANSPORTER: increase in dihydrofluorescein intracellular accumulation (dihydrofluorescein: 1 uM) in SK-E2 cells (expressing BSEP) | F | 5.11 | pIC50 | 7800 | nM | IC50 | Pharm. Res. (2003) 20: 537-544 [PMID:12739759] |
ChEMBL | TP_TRANSPORTER: increase in bodipy intracellular accumulation (Bodipy: 0.2 uM) in SK-E2 cells (expressing BSEP) | F | 5.12 | pIC50 | 7500 | nM | IC50 | Pharm. Res. (2003) 20: 537-544 [PMID:12739759] |
ChEMBL | Inhibition of human BSEP expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 6.3 | pIC50 | 500 | nM | IC50 | Drug Metab. Dispos. (2012) 40: 130-138 [PMID:21965623] |
ABCB11/Bile salt export pump in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073674] [GtoPdb: 778] [UniProtKB: O70127] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Taurocholate uptake in membrane vesicles from Bsep-expressing Sf9 cells | F | 6.52 | pKi | 300 | nM | Ki | Gastroenterology (2000) 118: 422-430 [PMID:10648470] |
ChEMBL | Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake | B | 6.22 | pIC50 | 600 | nM | IC50 | Drug Metab. Dispos. (2012) 40: 130-138 [PMID:21965623] |
Calcineurin B alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2082] [UniProtKB: P63098] | ||||||||
ChEMBL | Inhibition of CNB (unknown origin) using p-NPP as substrate preincubated for 10 mins followed by substrate addition by spectrophotometry analysis | B | 4.47 | pIC50 | 34000 | nM | IC50 | J Nat Prod (2021) 84: 1579-1586 [PMID:33973788] |
ABCC2/Canalicular multispecific organic anion transporter 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5748] [GtoPdb: 780] [UniProtKB: Q92887] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of BMG uptake in membrane vesicles from MRP2-expressing HEK cells | F | 4.68 | pKi | 21000 | nM | Ki | Hepatology (1999) 30: 485-490 [PMID:10421658] |
ChEMBL | TP_TRANSPORTER: inhibition of Vinblastine transepithelial transport (basal to apical) in MRP2-expressing MDCK cells | F | 5.09 | pKi | 8110 | nM | Ki | Pharm. Res. (2002) 19: 773-779 [PMID:12134946] |
ChEMBL | TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicles from MRP2-expressing LLC PK1 cells | F | 5.33 | pKi | 4700 | nM | Ki | Mol. Pharmacol. (1999) 56: 1219-1228 [PMID:10570049] |
ChEMBL | Inhibition of ABCC2 (unknown origin) expressed in MDCK2 cells assessed as inhibition of calcein-AM efflux measured after 30 mins in presence of ABCB1 inhibitor GF120918 and ABCC1 inhibitor MK-571 by flow cytometry | B | 4.59 | pIC50 | 25600 | nM | IC50 | Eur J Med Chem (2016) 122: 408-418 [PMID:27393949] |
ChEMBL | Inhibition of ABCC2 (unknown origin) | B | 4.7 | pIC50 | 20000 | nM | IC50 | Eur J Med Chem (2016) 122: 408-418 [PMID:27393949] |
ChEMBL | Inhibition of sulfasalazine-stimulated MRP2 ATPase activity (unknown origin) in presence of GSH | B | 4.79 | pIC50 | 16270 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
ChEMBL | Inhibition of human MRP2 expressed in dog MDCK2 cells | B | 4.87 | pIC50 | 13600 | nM | IC50 | Bioorg. Med. Chem. Lett. (2008) 18: 4761-4763 [PMID:18707884] |
ABCC2/Canalicular multispecific organic anion transporter 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2073676] [GtoPdb: 780] [UniProtKB: Q63120] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of BMG uptake in membrane vesicles from Mrp2-expressing HEK cells | F | 5 | pKi | 10000 | nM | Ki | Hepatology (1999) 30: 485-490 [PMID:10421658] |
ChEMBL | TP_TRANSPORTER: inhibition of DNP-SG uptake in bile canalicular membrane vesicles from SD rat | F | 5.71 | pKi | 1960 | nM | Ki | Drug Metabol. Pharmacokin. (2002) 17: 23-33 [PMID:15618649] |
ABCC3/Canalicular multispecific organic anion transporter 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5918] [GtoPdb: 781] [UniProtKB: O15438] | ||||||||
ChEMBL | Inhibition of benzmarone-stimulated MRP3 ATPase activity (unknown origin) in presence of GSH | B | 6.2 | pIC50 | 631.5 | nM | IC50 | J Med Chem (2021) 64: 3677-3693 [PMID:33729781] |
peptidylprolyl isomerase A/Cyclophilin A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1949] [GtoPdb: 2751] [UniProtKB: P62937] | ||||||||
ChEMBL | Binding affinity to Cyclophilin A | B | 5.19 | pKd | 6420 | nM | Kd | Eur. J. Med. Chem. (2011) 46: 1701-1705 [PMID:21396746] |
ChEMBL | Binding affinity towards cyclophilin A by fluorescence | B | 6.52 | pKd | 300 | nM | Kd | J. Med. Chem. (2001) 44: 2593-2600 [PMID:11472213] |
ChEMBL | Binding affinity to human Cyclophilin A | B | 7.43 | pKd | 36.8 | nM | Kd | Bioorg. Med. Chem. Lett. (2008) 18: 3995-3998 [PMID:18571405] |
ChEMBL | Inhibition of Cy5-labeled cyclosporin A binding to full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) after 30 mins by TR-FRET assay | B | 7.77 | pKd | 17 | nM | Kd | J Med Chem (2018) 61: 9473-9499 [PMID:30074795] |
ChEMBL | Inhibition of Cy5-labeled cyclosporin A binding to full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) after 2 hrs by TR-FRET assay | B | 7.77 | pKd | 17 | nM | Kd | J Med Chem (2017) 60: 1000-1017 [PMID:28075591] |
ChEMBL | Competitive binding affinity to biotinylated human recombinant T cell cyclophilin A expressed in Escherichia coli by spectrophotometric analysis | B | 8 | pKd | 10 | nM | Kd | ACS Med. Chem. Lett. (2011) 2: 485-487 [PMID:24900335] |
ChEMBL | Binding affinity to cyclophilin A by surface plasmon resonance analysis | B | 8 | pKd | 10 | nM | Kd | ACS Med. Chem. Lett. (2011) 2: 485-487 [PMID:24900335] |
ChEMBL | Binding affinity to human cyclophilin A by fluorescence polarization assay | B | 8 | pKd | 10 | nM | Kd | ACS Med. Chem. Lett. (2011) 2: 485-487 [PMID:24900335] |
ChEMBL | Inhibition of fluorescent cyclosporin A binding to human CypA by TR-FRET assay | B | 8 | pKd | 10 | nM | Kd | Bioorg Med Chem Lett (2016) 26: 5304-5307 [PMID:27687672] |
ChEMBL | Binding affinity to human cyclophilin 18 assessed as reduction in calcineurin activity | B | 8.05 | pKd | 9 | nM | Kd | Nat. Chem. Biol. (2009) 5: 724-726 [PMID:19734911] |
ChEMBL | Binding affinity to human recombinant cyclophilin-A by isothermal titration calorimetry assay | B | 8.12 | pKd | 7.6 | nM | Kd | Eur. J. Med. Chem. (2011) 46: 5556-5561 [PMID:21963115] |
ChEMBL | Inhibition of fluorescein labeled cyclosporin binding to Cyp18 by fluorescence polarization competition assay | B | 6.64 | pKi | 231 | nM | Ki | ACS Med. Chem. Lett. (2010) 1: 536-539 [PMID:24900244] |
ChEMBL | Inhibition of Cyclophilin 18 PPIase activity | B | 6.64 | pKi | 227 | nM | Ki | ACS Med. Chem. Lett. (2010) 1: 536-539 [PMID:24900244] |
ChEMBL | Inhibition of cyclophilin A rotamase | B | 7.7 | pKi | 20 | nM | Ki | Bioorg. Med. Chem. Lett. (2004) 14: 4549-4551 [PMID:15357990] |
GtoPdb | - | - | 7.76 | pKi | 17.2 | nM | Ki | J Pharmacol Exp Ther (2019) 371: 231-241 [PMID:31406003] |
ChEMBL | Inhibition of CypA PPIase activity (unknown origin) using Glt-(Ala)n-Pro-Phe-4-nitroanilides as substrate | B | 7.91 | pKi | 12.2 | nM | Ki | J. Med. Chem. (2013) 56: 7302-7311 [PMID:23964991] |
ChEMBL | Inhibition of human recombinant cyclophilin-associted cis-trans propyl isomerase activity | B | 8.01 | pKi | 9.79 | nM | Ki | Antimicrob. Agents Chemother. (2008) 52: 1302-1317 [PMID:18212100] |
ChEMBL | Inhibition of full length recombinant human N-terminal His8-tagged Cyclophilin A (1 to 169 residues) expressed in Escherichia coli BL21(DE3) using Suc-Ala-Ala-Pro-Phe-para-nitroanilide as substrate after 5 mins by spectrophotometric method | B | 8.17 | pKi | 6.7 | nM | Ki | J Med Chem (2017) 60: 1000-1017 [PMID:28075591] |
ChEMBL | Inhibition of calcineurin phosphatase activity of CyPA | B | 8.58 | pKi | 2.64 | nM | Ki | Antimicrob. Agents Chemother. (2010) 54: 660-672 [PMID:19933795] |
ChEMBL | Inhibition of recombinant GST-tagged CypA (unknown origin)/HCV Con1 NS5A-His interaction after 16 hrs by ELISA | B | 6.02 | pIC50 | 950 | nM | IC50 | MedChemComm (2012) 3: 944-949 |
ChEMBL | Binding affinity to human cyclophilin 18 | B | 7 | pIC50 | 100 | nM | IC50 | Nat. Chem. Biol. (2009) 5: 724-726 [PMID:19734911] |
ChEMBL | In vitro binding affinity against cyclophilin A by ELISA | B | 7.21 | pIC50 | 62 | nM | IC50 | J. Med. Chem. (1995) 38: 3361-3367 [PMID:7650689] |
ChEMBL | Inhibition of peptidyl-prolyl isomerase activity of Cyclophilin A | B | 7.39 | pIC50 | 40.7 | nM | IC50 | J. Med. Chem. (2009) 52: 5295-5298 [PMID:19691347] |
ChEMBL | In vitro binding affinity against cyclophilin A by rotamase assay | B | 7.57 | pIC50 | 27 | nM | IC50 | J. Med. Chem. (1995) 38: 3361-3367 [PMID:7650689] |
ChEMBL | Inhibition of CypA (unknown origin) assessed as peptidyl-prolyl cis-trans isomerase activity using N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as substrate by spectrophotometry | B | 7.64 | pIC50 | 23 | nM | IC50 | Bioorg. Med. Chem. Lett. (2015) 25: 5682-5686 [PMID:26564266] |
ChEMBL | Inhibition of PPIase activity of Cyclophilin A by Spectrophotometry | B | 7.99 | pIC50 | 10.25 | nM | IC50 | Eur. J. Med. Chem. (2011) 46: 1701-1705 [PMID:21396746] |
ChEMBL | Inhibition of PPIase activity of recombinant CypA (unknown origin) assessed as chymotrypsin-mediated N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide hydrolysis after 1 hr by spectrophotometric analysis | B | 8.02 | pIC50 | 9.6 | nM | IC50 | MedChemComm (2012) 3: 944-949 |
ChEMBL | Inhibition of PPIase activity of human recombinant cyclophilin-A using succinyl-Ala-Ala-Pro-Phe-4-nitroanilide as substrate by protease coupled assay | B | 8.03 | pIC50 | 9.3 | nM | IC50 | Eur. J. Med. Chem. (2011) 46: 5556-5561 [PMID:21963115] |
ChEMBL | Compound was evaluated for in vitro binding affinity to cyclophilin A (CyP-A) | B | 8.05 | pIC50 | 9 | nM | IC50 | J. Med. Chem. (1994) 37: 3674-3676 [PMID:7966126] |
ChEMBL | Binding affinity to cyclophilin A by ELISA | B | 8.08 | pIC50 | 8.33 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 6542-6546 [PMID:20943390] |
ChEMBL | Inhibition of Cyclophilin A peptidyl-prolyl cis-trans isomerase activity (unknown origin) using Succ-Ala-Leu-Pro-Phe-p-nitroaniline as substrate by ITC analysis | B | 8.14 | pIC50 | 7.2 | nM | IC50 | J. Med. Chem. (2015) 58: 9546-9561 [PMID:26613291] |
GtoPdb | - | - | 8.3 | pIC50 | 5 | nM | IC50 | Proc Natl Acad Sci USA (1992) 89: 3686-90 [PMID:1373887] |
ChEMBL | Inhibition of PPIase activity of cyclophilin 18 by protease coupled assay | B | 8.43 | pIC50 | 3.7 | nM | IC50 | Nat. Chem. Biol. (2009) 5: 724-726 [PMID:19734911] |
ChEMBL | Immunosuppressive activity was measured by inhibition of the IL-2 production in Jurkat cells. | F | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg. Med. Chem. Lett. (2003) 13: 4415-4419 [PMID:14643337] |
Cyclophilin B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2075] [UniProtKB: P23284] | ||||||||
ChEMBL | Binding affinity to human Cyclophilin B | B | 8.01 | pKd | 9.8 | nM | Kd | Bioorg. Med. Chem. Lett. (2008) 18: 3995-3998 [PMID:18571405] |
ChEMBL | Binding affinity to cyclophilin B by ELISA | B | 8.06 | pIC50 | 8.78 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 6542-6546 [PMID:20943390] |
CYP3A4/Cytochrome P450 3A4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL340] [GtoPdb: 1337] [UniProtKB: P08684] | ||||||||
ChEMBL | null: A commercially available P450-GLO Assay kit (Promega Corporation, Madison Wis.) is used to screen various compounds for CYP3A4A inhibition activity. CYP3A4A is thought to be one of the primary CYP isoforms responsible for retinoic acid metabolism in the skin. Three benchmark agents, liarozole, climbazole, and ketoconazole, were assessed for CYP3A4 inhibition to confirm that the inhibition activity (the IC50 for CYP3A4 inhibition) measured by the assay corresponds to the activity reported by the published literature. The results show that the substituted azole compounds having the specific structure set forth herein are CYP inhibitors, and thus function as RAMBAs. | B | 5 | pIC50 | >10000 | nM | IC50 | US-9138393-B2. Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin (2015) |
dihydroorotate dehydrogenase (quinone)/Dihydroorotate dehydrogenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1966] [GtoPdb: 2604] [UniProtKB: Q02127] | ||||||||
ChEMBL | In vitro inhibitory activity against human dihydroorotate dehydrogenase (DHODH) | B | 4.3 | pIC50 | >50000 | nM | IC50 | J. Med. Chem. (1998) 41: 3530-3538 [PMID:9719606] |
FKBP prolyl isomerase 1A/FK506-binding protein 1A in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1902] [GtoPdb: 2609] [UniProtKB: P62942] | ||||||||
ChEMBL | Compound was tested for its ability to inhibit FK506 binding protein 12 rotamase activity | B | 7.7 | pKi | 20 | nM | Ki | J. Med. Chem. (1998) 41: 5119-5143 [PMID:9857082] |
FK506-binding protein 1B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2430] [UniProtKB: P68106] | ||||||||
ChEMBL | The compound was tested for inhibition of Peptidyl-propyl isomerase (PPIase). | B | 8.22 | pKi | 6 | nM | Ki | J. Med. Chem. (1995) 38: 4164-4170 [PMID:7473543] |
FKBP prolyl isomerase 4/FK506 binding protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4050] [GtoPdb: 3176] [UniProtKB: Q02790] | ||||||||
ChEMBL | 50% inhibitory concentration of competitive binding against hCyp-18 PPIase activity using uncoupled assay | B | 7.8 | pIC50 | 16 | nM | IC50 | J. Med. Chem. (2000) 43: 1770-1779 [PMID:10794694] |
FPR1/Formyl peptide receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3359] [GtoPdb: 222] [UniProtKB: P21462] | ||||||||
ChEMBL | Inhibitory activity against human formylpeptide receptor (FPR) of human leukemia HL-60 cells | B | 5 | pIC50 | >10000 | nM | IC50 | J. Med. Chem. (2002) 45: 4613-4628 [PMID:12361388] |
GtoPdb | - | - | 6.3 | pEC50 | - | - | - | Biochem Pharmacol (1997) 54: 695-701 [PMID:9310346] |
Human immunodeficiency virus type 1 reverse transcriptase in Human immunodeficiency virus 1 (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL247] [UniProtKB: Q72547] | ||||||||
ChEMBL | In vitro inhibitory activity against HIV-1 RT in CEM4 cell line | B | 6.34 | pIC50 | 455 | nM | IC50 | Bioorg. Med. Chem. Lett. (2003) 13: 4415-4419 [PMID:14643337] |
Sodium/bile acid and sulphated solute cotransporter 2/Ileal bile acid transporter in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2778] [GtoPdb: 960] [UniProtKB: Q12908] | ||||||||
ChEMBL | TP_TRANSPORTER: inhibition of Taurocholate uptake in ASBT-expressing COS cells | F |